These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 7925116

  • 1. Corticotropin-releasing factor receptors in human small cell lung carcinoma cells: radioligand binding, second messenger, and northern blot analysis data.
    Dieterich KD, Grigoriadis DE, De Souza EB.
    Endocrinology; 1994 Oct; 135(4):1551-8. PubMed ID: 7925116
    [Abstract] [Full Text] [Related]

  • 2. Solubilization of high affinity corticotropin-releasing factor receptors from rat brain: characterization of an active digitonin-solubilized receptor complex.
    Grigoriadis DE, Zaczek R, Pearsall DM, De Souza EB.
    Endocrinology; 1989 Dec; 125(6):3068-77. PubMed ID: 2555137
    [Abstract] [Full Text] [Related]

  • 3. Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.
    Myers DA, Trinh JV, Myers TR.
    Mol Cell Endocrinol; 1998 Sep 25; 144(1-2):21-35. PubMed ID: 9863624
    [Abstract] [Full Text] [Related]

  • 4. Corticotropin-releasing factor receptors in mouse spleen: identification, autoradiographic localization, and regulation by divalent cations and guanine nucleotides.
    Webster EL, De Souza EB.
    Endocrinology; 1988 Feb 25; 122(2):609-17. PubMed ID: 2828007
    [Abstract] [Full Text] [Related]

  • 5. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE, Liu XJ, Vaughn J, Palmer SF, True CD, Vale WW, Ling N, De Souza EB.
    Mol Pharmacol; 1996 Sep 25; 50(3):679-86. PubMed ID: 8794910
    [Abstract] [Full Text] [Related]

  • 6. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.
    Nakanishi Y, Mulshine JL, Kasprzyk PG, Natale RB, Maneckjee R, Avis I, Treston AM, Gazdar AF, Minna JD, Cuttitta F.
    J Clin Invest; 1988 Jul 25; 82(1):354-9. PubMed ID: 2839551
    [Abstract] [Full Text] [Related]

  • 7. Corticotropin-releasing factor binding to the anterior pituitary receptor is modulated by divalent cations and guanyl nucleotides.
    Perrin MH, Haas Y, Rivier JE, Vale WW.
    Endocrinology; 1986 Mar 25; 118(3):1171-9. PubMed ID: 3004898
    [Abstract] [Full Text] [Related]

  • 8. Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors: decreased coupling efficiency of human type II CRF receptor.
    Xiong Y, Xie LY, Abou-Samra AB.
    Endocrinology; 1995 May 25; 136(5):1828-34. PubMed ID: 7720627
    [Abstract] [Full Text] [Related]

  • 9. Human small cell lung cancer cell lines express functional atrial natriuretic peptide receptors.
    Ohsaki Y, Yang HK, Le PT, Jensen RT, Johnson BE.
    Cancer Res; 1993 Jul 01; 53(13):3165-71. PubMed ID: 8391389
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological characterization of a novel nonpeptide antagonist radioligand, (+/-)-N-[2-methyl-4-methoxyphenyl]-1-(1-(methoxymethyl) propyl)-6-methyl-1H-1,2,3-triazolo[4,5-c]pyridin-4-amine ([3H]SN003) for corticotropin-releasing factor1 receptors.
    Zhang G, Huang N, Li YW, Qi X, Marshall AP, Yan XX, Hill G, Rominger C, Prakash SR, Bakthavatchalam R, Rominger DH, Gilligan PJ, Zaczek R.
    J Pharmacol Exp Ther; 2003 Apr 01; 305(1):57-69. PubMed ID: 12649353
    [Abstract] [Full Text] [Related]

  • 11. Upregulation of interleukin-1 receptors in mouse AtT-20 pituitary tumor cells following treatment with corticotropin-releasing factor.
    Webster EL, Tracey DE, De Souza EB.
    Endocrinology; 1991 Nov 01; 129(5):2796-8. PubMed ID: 1834455
    [Abstract] [Full Text] [Related]

  • 12. Corticotropin-releasing factor (CRF) receptors in intermediate lobe of the pituitary: biochemical characterization and autoradiographic localization.
    Grigoriadis DE, De Souza EB.
    Peptides; 1989 Nov 01; 10(1):179-88. PubMed ID: 2546128
    [Abstract] [Full Text] [Related]

  • 13. Characterization of corticotropin-releasing factor receptor-mediated adenylate cyclase activity in the rat central nervous system.
    Battaglia G, Webster EL, De Souza EB.
    Synapse; 1987 Nov 01; 1(6):572-81. PubMed ID: 2843998
    [Abstract] [Full Text] [Related]

  • 14. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
    Wang WL, Healy ME, Sattler M, Verma S, Lin J, Maulik G, Stiles CD, Griffin JD, Johnson BE, Salgia R.
    Oncogene; 2000 Jul 20; 19(31):3521-8. PubMed ID: 10918610
    [Abstract] [Full Text] [Related]

  • 15. Effects of bombesin on human small cell lung cancer cells: evidence for a subset of bombesin non-responsive cell lines.
    Kado-Fong H, Malfroy B.
    J Cell Biochem; 1989 Aug 20; 40(4):431-7. PubMed ID: 2550492
    [Abstract] [Full Text] [Related]

  • 16. Functional corticotropin-releasing factor receptors in human neuroblastoma cells.
    Dieterich KD, DeSouza EB.
    Brain Res; 1996 Sep 09; 733(1):113-8. PubMed ID: 8891255
    [Abstract] [Full Text] [Related]

  • 17. Identification of a corticotropin-releasing factor-binding protein in the plasma membrane of AtT-20 mouse pituitary tumor cells and its regulation by dexamethasone.
    Rosendale BE, Jarrett DB, Robinson AG.
    Endocrinology; 1987 Jun 09; 120(6):2357-66. PubMed ID: 3032586
    [Abstract] [Full Text] [Related]

  • 18. Monkey corticotropin-releasing factor1 receptor: Complementary DNA cloning and pharmacological characterization.
    Oshida Y, Ikeda Y, Chaki S, Okuyama S.
    Life Sci; 2004 Feb 27; 74(15):1911-24. PubMed ID: 14761672
    [Abstract] [Full Text] [Related]

  • 19. Corticotropin-releasing factor receptors in the rat central nervous system: characterization and regional distribution.
    De Souza EB.
    J Neurosci; 1987 Jan 27; 7(1):88-100. PubMed ID: 3027279
    [Abstract] [Full Text] [Related]

  • 20. Human CRF2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay.
    Ardati A, Goetschy V, Gottowick J, Henriot S, Valdenaire O, Deuschle U, Kilpatrick GJ.
    Neuropharmacology; 1999 Mar 27; 38(3):441-8. PubMed ID: 10219982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.